We are live on ! Find out more
AICPI

ABG Innovation Capital Partners III Portfolio holdings

AUM $64.5K
1-Year Est. Return 1.01%
This Fund
S&P 500
This Quarter Est. Return
-1.89%
1 Year Est. Return
+1.01%
3 Year Est. Return
+5.56%
5 Year Est. Return
-85.52%
10 Year Est. Return
AUM
$1.08M
AUM Growth
-$40.8K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSTL icon
1
Castle Biosciences
CSTL
$949M
$979K 90.45%
36,747
WHWK
2
Whitehawk Therapeutics
WHWK
$209M
$84.1K 7.77%
26,666
SYBX
3
DELISTED
Synlogic
SYBX
$19.2K 1.78%
13,727

Similar funds

ABG Innovation Capital Partners III's Q4 2024 Portfolio in Review

As of Q4 2024, ABG Innovation Capital Partners III held 3 positions worth $1.08M, down 3.6% from $1.12M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 0%. ABG Innovation Capital Partners III opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG Innovation Capital Partners III's ten largest holdings make up 100% of its $1.08M portfolio in Q4 2024.
  • ABG Innovation Capital Partners III opened 0 new positions and closed 0 in Q4 2024.
  • ABG Innovation Capital Partners III's portfolio value fell 3.6% quarter-over-quarter to $1.08M.

Based on ABG Innovation Capital Partners III's 13F filing for Q4 2024, filed 14 Feb 2025.